30 min listen
Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19
Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19
ratings:
Length:
16 minutes
Released:
Jun 6, 2022
Format:
Podcast episode
Description
CHEST June 2022, Volume 161, Issue 6
David Jimenez, MD, PhD, and Tobias Tritschler, MD, MSc, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss whether therapeutic heparin should be administered to acutely-ill hospitalized patients with COVID-19.
DOI: https://doi.org/10.1016/j.chest.2022.01.036
DOI: https://doi.org/10.1016/j.chest.2022.01.037
DOI: https://doi.org/10.1016/j.chest.2022.01.038
DOI: https://doi.org/10.1016/j.chest.2022.01.039
David Jimenez, MD, PhD, and Tobias Tritschler, MD, MSc, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss whether therapeutic heparin should be administered to acutely-ill hospitalized patients with COVID-19.
DOI: https://doi.org/10.1016/j.chest.2022.01.036
DOI: https://doi.org/10.1016/j.chest.2022.01.037
DOI: https://doi.org/10.1016/j.chest.2022.01.038
DOI: https://doi.org/10.1016/j.chest.2022.01.039
Released:
Jun 6, 2022
Format:
Podcast episode
Titles in the series (100)
The Future of Lung Transplantation: Steven D. Nathan, MD, FCCP, is interviewed by CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, on his commentary discussing near- and long-term trends in lung transplantation, including new criteria for donors, procedures, and novel therapies. by CHEST Journal Podcasts